trial · primary record
AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion
Advanced Malignant Tumors
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 70 |
| Primary completion | 2026-03-04 |
| Primary endpoint | Incidence and severity of adverse events(AE); |
| Registry ID | NCT05868876 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:06.755Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05868876
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.